BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9217288)

  • 1. Immunotherapy for insulin-dependent diabetes mellitus in the "BB" rat.
    Thliveris JA; Begleiter A; Manchur D; Johnston JB
    Life Sci; 1997; 61(3):283-91. PubMed ID: 9217288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional status of the immune system after chronic administration of 2'-deoxycoformycin in the BB rat.
    Thliveris JA; HayGlass KT; Manchur D; Rector E; Begleiter A; Johnston JB
    Histol Histopathol; 2000 Jan; 15(1):21-7. PubMed ID: 10668191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of insulin-dependent diabetes mellitus by 2'-deoxycoformycin in the BB Wistar rat.
    Thliveris JA; Begleiter A; Kobrinsky NL; Verburg L; Dean HJ; Johnston JB
    Biochem Pharmacol; 1993 Sep; 46(6):1071-5. PubMed ID: 8216350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive effect of 2'-deoxycoformycin (Pentostatin) for rat islet allotransplantation.
    Ar'Rajab A; Harris RB; Khair-el-Din TA; Sentementes JT; Lu C; Dawidson IJ
    Cell Transplant; 1995; 4(3):315-21. PubMed ID: 7640871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dithiocarbamate analogue decreases intraislet cell infiltration and the incidence of diabetes mellitus in the genetic diabetes-prone BB rat.
    Pieper GM; Henderson JD; Roza AM; Lai CS
    Pancreas; 2004 Jan; 28(1):e16-25. PubMed ID: 14707744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma interferon prevents diabetes in the BB rat.
    Sobel DO; Newsome J
    Clin Diagn Lab Immunol; 1997 Nov; 4(6):764-8. PubMed ID: 9384304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral autoimmunity in the pathogenesis of insulin-dependent diabetes mellitus. Studies in the spontaneously diabetic BB rat.
    Dyrberg T
    Acta Endocrinol Suppl (Copenh); 1986; 280():1-29. PubMed ID: 2429489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of FK506 on the development of diabetes in BB rats in comparison with that of cyclosporin.
    Wakugami T; Islam MR; Higa S; Murakami K; Mimura G
    Tohoku J Exp Med; 1993 Jan; 169(1):21-9. PubMed ID: 7692621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
    Sobel DO; Goyal D; Ahvazi B; Yoon JW; Chung YH; Bagg A; Harlan DM
    J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical antidiabetogenic effect of gamma-interferon in DP-BB rats.
    Nicoletti F; Zaccone P; Di Marco R; Magro G; Grasso S; Stivala F; Calori G; Mughini L; Meroni PL; Garotta G
    Diabetes; 1998 Jan; 47(1):32-8. PubMed ID: 9421371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine pancreas histology of congenic BB-rat strains with reduced diabetes incidence after genetic manipulation on chromosomes 4, 6 and X.
    Lucke S; Klöting I; Pusch A; Heinrich HW; Hahn HJ
    Autoimmunity; 2003 May; 36(3):143-9. PubMed ID: 12911280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of deoxyspergualin (DSP) and cyclosporin A (CsA) in the prevention of spontaneous autoimmune diabetes in BB rats.
    Di Marco R; Zaccone P; Magro G; Grasso S; Lunetta M; Barcellini W; Nicolosi VM; Meroni PL; Nicoletti F
    Clin Exp Immunol; 1996 Aug; 105(2):338-43. PubMed ID: 8706343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats.
    Satoh J; Shintani S; Oya K; Tanaka S; Nobunaga T; Toyota T; Goto Y
    Diabetes; 1988 Sep; 37(9):1188-94. PubMed ID: 3044884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of diabetes and induction of non-specific suppressor cell activity in the BB rat by an immunomodulatory azaspirane, SK&F 106610.
    Rabinovitch A; Suarez WL; Qin HY; Power RF; Badger AM
    J Autoimmun; 1993 Feb; 6(1):39-49. PubMed ID: 8457285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of deoxyspergualin on the development of diabetes in diabetes-prone BB rats.
    Nicoletti F; Meroni PL; Di Marco R; Grasso S; Barcellini W; Borghi MO; Lunetta M; Mughini L; Menta R; Schorlemmer HU
    Scand J Immunol; 1992 Sep; 36(3):415-20. PubMed ID: 1519035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abrogation of diabetes in BB rats by acute virus infection. Association of viral-lymphocyte interactions.
    Schwimmbeck PL; Dyrberg T; Oldstone MB
    J Immunol; 1988 May; 140(10):3394-400. PubMed ID: 3283232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide inhibits the development of diabetes in the diabetes-prone BB rat.
    Sobel DO; Ahvazi B; Jun HS; Chung YH; Yoon JW
    Diabetologia; 2000 Aug; 43(8):986-94. PubMed ID: 10990075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effects of interleukin-1 beta on blood leukocytes in BB rats prone or resistant to diabetes.
    Jobe LW; Vertrees S; Wilson CA; Jacobs C; Wilson DL; Picha KS; Baker P; Lernmark A
    Autoimmunity; 1992; 11(4):233-7. PubMed ID: 1581467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of autoimmune serological reactions in rodent models of insulin dependent diabetes mellitus.
    Mackay IR; Bone A; Tuomi T; Elliott R; Mandel T; Karopoulos C; Rowley MJ
    J Autoimmun; 1996 Dec; 9(6):705-11. PubMed ID: 9115572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of type I diabetes with lymphotoxin in BB rats.
    Takahashi K; Satoh J; Seino H; Zhu XP; Sagara M; Masuda T; Toyota T
    Clin Immunol Immunopathol; 1993 Dec; 69(3):318-23. PubMed ID: 8242903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.